BangladeshTaevas Global helps international medical devices companies identify, qualify, and contract with compliant local manufacturers in Bangladesh, accelerating DGDA registration and market entry while reducing regulatory and operational risk.
Our six interconnected pillars give medical devices companies a complete operational and regulatory picture needed to source, qualify, and activate a local manufacturer in Bangladesh.
We decode the full DGDA regulatory framework governing medical devices in Bangladesh, including device classification, registration pathways, and import licensing requirements. Our team tracks the Medical Device Regulation currently being finalized under the Drug Act 1940 and subsequent amendments, ensuring your entry strategy is built on current law. You receive a clear compliance roadmap before committing resources.
Our four-stage engagement moves from scoping your device portfolio and regulatory requirements through manufacturer identification, due diligence, and final strategy delivery in a structured six-week process.
We conduct a structured intake session with your regulatory, commercial, and operations teams to understand your device portfolio, target classifications, existing certifications, and strategic priorities for Bangladesh. This session defines the scope of manufacturer search, compliance requirements, and commercial constraints. A detailed project brief is agreed and signed off before research begins.
Intake covers device risk classification, existing ISO 13485 or CE mark status, technology transfer readiness, budget parameters for local manufacturing arrangements, and preferred timeline for DGDA registration. We also identify any prior Bangladesh market contacts or regulatory interactions your team has had, to avoid duplication and build on existing groundwork.
Bangladesh has significantly increased public and private healthcare investment over the past decade, with the government expanding district hospitals, specialized institutes, and primary care facilities under successive five-year plans. This infrastructure growth is driving sustained demand for diagnostic equipment, surgical instruments, consumables, and patient monitoring devices. Foreign manufacturers who establish a local presence now are positioned to capture procurement contracts as the healthcare system scales.
The Directorate General of Drug Administration currently regulates medical devices under the Drug Act 1940, but Bangladesh is advancing a dedicated Medical Devices Regulation that is expected to introduce formal risk-based classification, mandatory technical documentation, and post-market surveillance requirements aligned with international frameworks. Companies entering now through a compliant local manufacturer arrangement will be better positioned to transition smoothly when the new regulation takes effect. Early regulatory engagement is a competitive advantage.
Bangladesh currently imports the vast majority of its medical devices, with significant volumes sourced from China, India, Germany, and the United States. The government has signaled policy intent to encourage local manufacturing of medical devices through industrial policy incentives, creating an opening for foreign companies to establish local manufacturer partnerships that reduce import duties and improve supply chain resilience. Technology transfer arrangements with local manufacturers are increasingly viewed favorably by DGDA.
The private healthcare sector in Bangladesh, including hospital chains, diagnostic centers, and specialty clinics concentrated in Dhaka and Chittagong, is a major and growing buyer of medical devices, often operating outside government procurement channels and capable of faster purchasing decisions. This sector is increasingly receptive to international device brands when supported by reliable local service and supply networks, which a local manufacturer partner can provide. Understanding private sector procurement dynamics is essential for commercial success.
Your Local Manufacturer engagement package delivers eight structured outputs covering regulatory intelligence, manufacturer due diligence, commercial structuring, and a market entry roadmap for Bangladesh.
A detailed analysis of DGDA requirements applicable to your device classes in Bangladesh, including registration pathway, technical documentation requirements, labeling obligations, and anticipated regulatory changes.
A structured longlist of DGDA-licensed manufacturers in Bangladesh screened against your device category, production capability, quality certifications, and technology transfer experience.
Detailed due diligence profiles for two to four shortlisted manufacturers covering quality management systems, regulatory compliance history, financial stability indicators, and IP risk assessment.
A scored comparison of shortlisted manufacturers against weighted compliance, commercial, and operational risk criteria, enabling objective partner selection decisions.
A phased market entry plan covering DGDA registration milestones, manufacturer activation, channel development, and localization options with timelines and resource estimates.
Benchmarked guidance on technology transfer terms, quality agreement structure, exclusivity provisions, and pricing models for local manufacturer agreements in the Bangladesh medical devices sector.
An assessment of international and domestic competitors already operating through local manufacturer arrangements in Bangladesh, including their device portfolios, market positioning, and distribution strategies.
A mapping of key procurement decision-makers, hospital networks, government health agencies, and distribution channels relevant to your device category in the Bangladesh market.
You are a medical devices company based in Europe, North America, or Asia that has identified Bangladesh as a priority emerging market but lacks the local regulatory knowledge, manufacturer contacts, and compliance infrastructure to enter confidently. You need a structured, evidence-based approach to identifying a credible local manufacturer and navigating DGDA requirements without expensive trial and error. Taevas Global compresses your learning curve and reduces first-mover risk.
Connect with Taevas Global to start your Local Manufacturer engagement for Medical Devices in Bangladesh and receive a tailored proposal within 48 hours.